Combined Sofosbuvir/Daclatasvir and Chemotherapy Markedly Improve The Outcome of B-Lymphoid Malignancies in Patients with Both HCV Infection and B-Lymphoid Malignancy

Direct Acting Anti-Viral Therapy, and Potential Increase in the Incidence of Hepato-Cellular Carcinoma in Cirrhotic Patients With Hepatitis C Virus

Hematological Effects of Antiviral Drugs for Hepatitis C Virus

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Detecting Imaging For Neoplastic Liver Masses in Hepatic Patients Who Received Direct Acting Antiviral Drugs

B-cell monoclonal lymphocytosis in chronic hepatitis C virus infection

Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ?

Clinical Impact of Hepatitis C Virus in Patients with B-Cell Non-Hodgkin Lymphoma

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs